ARTV
ARTV
US04317A1079
Artiva Biotherapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
339.3M EUR
474.19M EUR
159.18M EUR
105.51M EUR
Enterprise Value
-7.09M EUR
182.59M EUR
148.48M EUR
89.76M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-2.66x
--
--
--
Price to Sales
--
--
--
--
Price to Book
0.97x
1.36x
1.81x
0.96x
EV/Revenue
--
--
--
--
EV/EBITDA
0.08x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-13.1%
-16.22%
-50.37%
-55.9%
ende